Cord Blood News Volume 4.13 | Apr 5 2012

Prenatally Engineered Autologous Amniotic Fluid Stem Cell-Based Heart Valves in the Fetal Circulation
The presented study investigates the fetal implantation of prenatally engineered living autologous cell-based heart valves. [Biomaterials] Abstract

Histone Deacetylase 3 (HDAC-3) Modulates the Expansion of Human Hematopoietic Stem Cells
Investigators have identified the valproic acid target HDAC3 as a negative regulator of umbilical cord blood hematopoietic stem cell expansion. [Stem Cells Dev] Abstract

Protein Segregation Between Dividing Hematopoietic Progenitor Cells in the Determination of the Symmetry/Asymmetry of Cell Division
Scientists investigated how the symmetry/asymmetry of cell division in mitotic CD34⁺ cells can be evaluated by determining the plane of cell division and the potential distribution of proteins between daughter cells. [Stem Cells Dev] Abstract

In Search for Cross-Reactivity to Immunophenotype Equine Mesenchymal Stromal Cells by Multicolor Flow Cytometry
Umbilical cord blood-derived undifferentiated equine mesenchymal stem cells of the fourth passage of six horses were characterized using multicolor flow cytometry based on the selected nine-marker panel of both cell surface antigens and intracytoplasmatic proteins. [Cytometry A] Abstract

Insulin-Like Growth Factor Binding Protein-2 and Neurotrophin 3 Synergize Together to Promote the Expansion of Hematopoietic Cells Ex Vivo
To determine whether neurotrophin-3 and insulin-like growth factor binding protein-2 are partly responsible for the growth promoting potential of mesenchymal stem cells, researchers investigated their impact on the growth and differentiation of umbilical cord blood-CD34⁺ cells. [Cytokine] Abstract

Survival of Cord Blood Hematopoietic Stem Cells in a Hyaluronan Hydrogel for Ex Vivo Biomimicry
The hyaluronic acid scaffold has been used for the first time to maintain long-term cultures of CD34⁺ hematopoietic cells obtained from human cord blood. [J Tissue Eng Regen Med] Abstract

Neuroprotective Effects of Human Umbilical Cord Mesenchymal Stromal Cells in an Immunocompetent Animal Model of Parkinson’s Disease
Scientists evaluated whether the transplantation of human mesenchymal stromal cells obtained from umbilical cord had a neuroprotective effect in a not-immunosuppressed rat Parkinson’s disease model. [J Neuroimmunol] Abstract

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

Visit our events page to see a complete list of events in the cord blood community.

Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.)

Scientist – Antibody and Hybridoma Technology Platforms (STEMCELL Technologies, Inc.)

Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.)

Scientist – Hematology (STEMCELL Technologies, Inc.)

Scientist – hPSC (STEMCELL Technologies, Inc.)

Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.)

Scientist – Endothelial Cells (STEMCELL Technologies, Inc.)

Business Analyst – Product Management (STEMSOFT Software, Inc.)

Stem Cell Technician (Kelly Scientific Resources)

Medical Technologist II – Cellular Therapy (San Diego Blood Bank)


Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe, Middle East to Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email info@connexoncreative.com with your feedback.